A phase II study of ramucirumab (IMC-1121B) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma

Richard T. Penson, Kathleen M. Moore, Gini F. Fleming, Patricia Braly, Veronica Schimp, Hoa Nguyen, Ursula A. Matulonis, Susana Banerjee, Paul Haluska, Martin Gore, Diane C. Bodurka, Rebecca R. Hozak, Adarsh Joshi, Yihuan Xu, Jonathan D. Schwartz, William P. McGuire

Research output: Contribution to journal › Article › peer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study of ramucirumab (IMC-1121B) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences